World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Medicine
UK
2026

D-Index & Metrics

Best Scientists

D-Index
172
Citations
165444
World Ranking
786
National Ranking
82

Medicine

D-Index
173
Citations
171772
World Ranking
463
National Ranking
55

Keith A.A. Fox publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Keith A.A. Fox sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,102 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Keith A.A. Fox D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Keith A.A. Fox sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 173 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Medicine in United Kingdom Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in United Kingdom Leader Award
  • 2023 - Research.com Medicine in United Kingdom Leader Award

Overview

Keith A.A. Fox is affiliated with the University of Edinburgh in the United Kingdom. Their research is primarily situated within the field of Medicine, with a strong focus on Cardiology and Cardiovascular Medicine, Surgery, Internal Medicine, Radiology, Nuclear Medicine and Imaging, and Economics and Econometrics.

The work of Keith A.A. Fox encompasses several key topics, including:

  • Atrial Fibrillation Management and Outcomes
  • Acute Myocardial Infarction Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac Imaging and Diagnostics
  • Coronary Interventions and Diagnostics
  • Acute Ischemic Stroke Management

Frequent co-authors collaborating with Keith A.A. Fox include:

  • Karen S. Pieper
  • John W. Eikelboom
  • Saverio Virdone
  • A. John Camm
  • Salim Yusuf

The researcher has published extensively in a range of venues, particularly:

  • European Heart Journal
  • Circulation
  • Journal of the American College of Cardiology
  • European Heart Journal - Cardiovascular Pharmacotherapy
  • Open Heart

Notable recent papers by Keith A.A. Fox include:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis, 2021, The Lancet
  • Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study, 2022, The Lancet
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis, 2021, The Lancet
  • Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries, 2021, Circulation
  • Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US, 2021, JAMA Cardiology

Best Publications

  • Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

    Manesh R. Patel;Kenneth W. Mahaffey;Jyotsna Garg;Guohua Pan

  • Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

    Shamir R. Mehta;Salim Yusuf;Ron J. G. Peters;Michel E. Bertrand

  • Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

    Deepak L. Bhatt;Keith A.A. Fox;Werner Hacke;Peter B. Berger

  • Universal definition of myocardial infarction.

    Kristian Thygesen;Joseph S. Alpert;Harvey D. White;Allan S. Jaffe

  • Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.

    Frans Van de Werf;Jeroen Bax;Amadeo Betriu;Carina Blomstrom-Lundqvist

  • Predictors of hospital mortality in the global registry of acute coronary events.

    Christopher B. Granger;Robert J. Goldberg;Omar Dabbous;Karen S. Pieper

  • Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

    J.P. Bassand;C.W. Hamm;D. Ardissino;E. Boersma

  • Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study

    Benjamin F. Voight;Benjamin F. Voight;Benjamin F. Voight;Gina M. Peloso;Gina M. Peloso;Marju Orho-Melander;Ruth Frikke-Schmidt

  • Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

    Jessica L. Mega;Eugene Braunwald;Stephen D. Wiviott;Jean-Pierre Bassand

  • ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

    R Collins;R Peto;M Flather;S Parish

  • Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais

  • Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

    Frans Van de Werf;Diego Ardissino;Amadeo Betriu;Dennis V. Cokkinos

  • A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.

    M. Cohen;C. Demers;E. P. Gurfinkel;A. G. G. Turpie

  • A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry

    Kim A Eagle;Michael J Lim;Omar H Dabbous;Karen S Pieper

  • Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

    Keith A A Fox;Omar H Dabbous;Robert J Goldberg;Karen S Pieper

  • Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes: Phase Z of the A to Z Trial

    James A de Lemos;Michael A. Blazing;Stephen D. Wiviott;Eldrin F. Lewis

  • Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes

    John W. Eikelboom;Shamir R. Mehta;Sonia S. Anand;Changchun Xie

  • Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart)

    James Nolan;Phillip D. Batin;Richard Andrews;Steven J. Lindsay

  • Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

    C Michael Gibson;Roxana Mehran;Christoph Bode;Jonathan Halperin

  • Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.

    E. M. Antman;C. H. Mccabe;E. P. Gurfinkel;A. G. G. Turpie

Frequent Co-Authors

Graeme J. Hankey
Graeme J. Hankey University of Western Australia
Manesh R. Patel
Manesh R. Patel Duke University
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Jonathan P. Piccini
Jonathan P. Piccini Duke University
Scott D. Berkowitz
Scott D. Berkowitz University of Colorado Anschutz Medical Campus
Richard C. Becker
Richard C. Becker University of Cincinnati
Jonathan L. Halperin
Jonathan L. Halperin Icahn School of Medicine at Mount Sinai
Daniel E. Singer
Daniel E. Singer Harvard University
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Shaun G. Goodman
Shaun G. Goodman University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn't always mean becoming a doctor. Many rewarding healthcare professions can be started or advanced through online study. For registered nurses looking for greater responsibility, adn to fnp programs provide a flexible route to becoming a Family Nurse Practitioner. These bridge programs allow you to build on your associate degree in nursing and move into advanced clinical roles.

For those interested in preventive health and dietary science, an online bachelor's in nutrition can open the door to careers in wellness coaching, public health, and clinical nutrition. These programs offer online flexibility while covering essential topics like metabolism and diet planning.

Healthcare management is another area of high demand. The best online mha programs are CAHME-accredited and designed for those aiming for leadership roles in hospitals, clinics, or healthcare systems. Many of these programs offer fully online coursework for working professionals.

Additionally, RNs seeking career advancement can find rn to bsn online with no clinicals options. These programs make it easier for nurses to earn their bachelor's degree without on-site clinical requirements, helping them step into higher-paying and more specialized nursing roles.

Best Scientists Citing Keith A.A. Fox

Trending Scientists

Recently Published Articles